Maoqun Tian

Title: Maoqun Tian: Innovator in Plasma Kallikrein Inhibitors

Introduction

Maoqun Tian is a notable inventor based in Forster, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of plasma kallikrein inhibitors. His work focuses on creating compounds that can effectively treat various disease states.

Latest Patents

Maoqun Tian holds 1 patent related to his innovative work. His patent, titled "Plasma Kallikrein Inhibitors," provides a compound of Formula (I) and pharmaceutical compositions that include one or more of these compounds. The methods outlined in his patent are aimed at treating or preventing conditions such as hereditary angioedema, uveitis, posterior uveitis, wet age-related macular edema, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. The compounds developed by Tian are selective inhibitors of plasma kallikrein, showcasing his expertise in this area.

Career Highlights

Maoqun Tian is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His role there has allowed him to contribute to groundbreaking research and development in the field of medicine. His work has the potential to impact the lives of many patients suffering from serious health conditions.

Collaborations

Maoqun Tian collaborates with various professionals in his field, including his coworker Salman Jabri. These collaborations enhance the research and development process, leading to more effective solutions in healthcare.

Conclusion

Maoqun Tian is a distinguished inventor whose work on plasma kallikrein inhibitors represents a significant advancement in pharmaceutical science. His contributions have the potential to improve treatment options for various diseases, highlighting the importance of innovation in healthcare.